Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Breast (Edinburgh, Scotland)|July 4, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsFabio Conforti, Laura Pala, Eleonora Pagan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2026
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort StudyCarmine Valenza, Yue Zheng, Monica Milano, et al.Current Oncology (Toronto, Ont.)|December 23, 2021
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II TrialSilvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, et al.Breast (Edinburgh, Scotland)|July 13, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancerEleonora Pagan, Monica Ruggeri, Nadia Bianco, et al.Journal of Cancer Survivorship : Research and Practice|June 10, 2022
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and SwitzerlandKarin Ribi, Eleonora Pagan, Isabella Sala, et al.BMC Geriatrics|June 24, 2026
Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocolChukwuma Okoye, Maria Cristina Ferrara, Beatrice Tonus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.The Lancet. Oncology|November 27, 2025
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trialsFabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast CancerFabio Conforti, Valentina Nekljudova, Isabella Sala, et al.Journal of the American College of Cardiology|April 18, 2020
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1Andrea Mazzanti, Dmitri Guz, Alessandro Trancuccio, et al.Pageof 7